• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆患者的突触前胆碱能功能障碍。

Presynaptic cholinergic dysfunction in patients with dementia.

作者信息

Sims N R, Bowen D M, Allen S J, Smith C C, Neary D, Thomas D J, Davison A N

出版信息

J Neurochem. 1983 Feb;40(2):503-9. doi: 10.1111/j.1471-4159.1983.tb11311.x.

DOI:10.1111/j.1471-4159.1983.tb11311.x
PMID:6822833
Abstract

Indices of presynaptic cholinergic nerve endings were assayed in neocortical biopsy samples from patients with presenile dementia. For those patients in whom Alzheimer's disease was histologically confirmed, [14C]acetylcholine synthesis, choline acetyltransferase activity and choline uptake were all found to be markedly reduced (at least 40%) below mean control values. The changes occurred in samples from both the frontal and temporal lobes and for [14C]acetylcholine synthesis the decrease was similar under conditions of high and low neuronal activity (as assessed by incubations in 31 mM and 5 mM K+ respectively). Samples from other demented patients, in whom the histological features of Alzheimer's disease were not detected, produced values for all three biochemical parameters which were similar to controls. For the total group of patients with presenile dementia there were correlations between values for the three markers of presynaptic cholinergic nerve endings suggestive of a loss of functional activity at these sites in Alzheimer's disease.

摘要

对早老性痴呆患者的新皮质活检样本中突触前胆碱能神经末梢指标进行了测定。对于那些经组织学确诊为阿尔茨海默病的患者,发现[14C]乙酰胆碱合成、胆碱乙酰转移酶活性和胆碱摄取均显著低于平均对照值(至少降低40%)。这些变化发生在额叶和颞叶的样本中,对于[14C]乙酰胆碱合成,在高神经元活性和低神经元活性条件下(分别通过在31 mM和5 mM K+中孵育评估)降低程度相似。在其他未检测到阿尔茨海默病组织学特征的痴呆患者样本中,所有三个生化参数的值与对照组相似。对于早老性痴呆患者的总体而言,突触前胆碱能神经末梢的三个标志物的值之间存在相关性,提示在阿尔茨海默病中这些部位存在功能活性丧失。

相似文献

1
Presynaptic cholinergic dysfunction in patients with dementia.痴呆患者的突触前胆碱能功能障碍。
J Neurochem. 1983 Feb;40(2):503-9. doi: 10.1111/j.1471-4159.1983.tb11311.x.
2
Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.阿尔茨海默病中与神经元活动相关的葡萄糖代谢和乙酰胆碱合成
Lancet. 1980 Feb 16;1(8164):333-6. doi: 10.1016/s0140-6736(80)90884-3.
3
Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy.在阿尔茨海默病患者的快速尸检材料中评估的突触前胆碱能功能的调节变化:对病因学和治疗的影响。
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2452-5. doi: 10.1073/pnas.87.7.2452.
4
Do raised brain aluminium levels in Alzheimer's dementia contribute to cholinergic neuronal deficits?阿尔茨海默病性痴呆中脑铝水平升高是否会导致胆碱能神经元缺陷?
Med Hypotheses. 1984 Jul;14(3):301-6. doi: 10.1016/0306-9877(87)90133-2.
5
Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.通过皮层内注射AF64A诱导皮层胆碱能功能减退和记忆保持缺陷。
Brain Res. 1988 Mar 15;444(1):104-18. doi: 10.1016/0006-8993(88)90918-3.
6
Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.痴呆患者活检额叶新皮质的胆碱乙酰转移酶活性与组织病理学
J Neurol Sci. 1982 Dec;57(2-3):191-202. doi: 10.1016/0022-510x(82)90026-0.
7
Nicotinic acetylcholine binding sites in Alzheimer's disease.阿尔茨海默病中的烟碱型乙酰胆碱结合位点
Brain Res. 1986 Apr 16;371(1):146-51. doi: 10.1016/0006-8993(86)90819-x.
8
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.新皮质胆碱能活动可区分路易体痴呆与经典阿尔茨海默病。
Neuroreport. 1994 Mar 21;5(7):747-9. doi: 10.1097/00001756-199403000-00002.
9
Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.阿尔茨海默病患者海马体和新皮质制备的突触体中高亲和力胆碱转运的证据。
Brain Res. 1983 Dec 19;289(1-2):169-75. doi: 10.1016/0006-8993(83)90017-3.
10
Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.阿尔茨海默病受累皮质区域中高亲和力胆碱转运体的过表达。来自快速尸检研究的证据。
J Clin Invest. 1994 Aug;94(2):696-702. doi: 10.1172/JCI117387.

引用本文的文献

1
Ethnopharmacological Profile, Phytochemistry and Therapeutic Potential of L. for the Treatment of Neurological Disorders.L. 用于治疗神经系统疾病的民族药理学概况、植物化学及治疗潜力
J Nutr Metab. 2025 Jun 11;2025:2275526. doi: 10.1155/jnme/2275526. eCollection 2025.
2
Studies and Antioxidant and Neuroprotective Assessment of Microencapsulated Celecoxib against Scopolamine-induced Alzheimer's Disease.微囊化塞来昔布对东莨菪碱诱导的阿尔茨海默病的研究及抗氧化和神经保护评估
Curr Pharm Des. 2025;31(4):320-329. doi: 10.2174/0113816128298289240723103828.
3
Neuroprotective Effect of Extract in Scopolamine-Induced Cognitive Impairment in Rats: Behavioral and Biochemical Approaches.
提取物对东莨菪碱诱导的大鼠认知障碍的神经保护作用:行为学和生物化学方法
Biology (Basel). 2024 Jun 9;13(6):426. doi: 10.3390/biology13060426.
4
Nootropic effect of Indian Royal Jelly against okadaic acid induced rat model of Alzheimer's disease: Inhibition of neuroinflammation and acetylcholineesterase.印度蜂王浆对冈田酸诱导的大鼠阿尔茨海默病模型的促智作用:抑制神经炎症和乙酰胆碱酯酶。
J Tradit Complement Med. 2023 Nov 15;14(3):300-311. doi: 10.1016/j.jtcme.2023.11.005. eCollection 2024 May.
5
Repurposing of Tibolone in Alzheimer's Disease.他莫昔芬在阿尔茨海默病中的再利用。
Biomolecules. 2023 Jul 13;13(7):1115. doi: 10.3390/biom13071115.
6
Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?激素替代疗法是阿尔茨海默病的危险因素还是治疗选择?
Int J Mol Sci. 2023 Feb 6;24(4):3205. doi: 10.3390/ijms24043205.
7
Flavonoid Derivatives as Potential Cholinesterase Inhibitors in Scopolamine-Induced Amnesic Mice: An In Vitro, In Vivo and Integrated Computational Approach.黄酮类衍生物作为东莨菪碱诱导的记忆缺失小鼠潜在的胆碱酯酶抑制剂:体外、体内及综合计算方法
Brain Sci. 2022 Jun 2;12(6):731. doi: 10.3390/brainsci12060731.
8
Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders.靶向毒蕈碱受体的药物设计及其对中枢神经系统疾病的影响
Biomedicines. 2022 Feb 7;10(2):398. doi: 10.3390/biomedicines10020398.
9
Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders.用于记忆和认知障碍的胆碱能深部脑刺激
J Alzheimers Dis. 2021;83(2):491-503. doi: 10.3233/JAD-210425.
10
Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex.阿尔茨海默病海马和内嗅皮层谷氨酸能受体表达变化。
Brain Pathol. 2021 Nov;31(6):e13005. doi: 10.1111/bpa.13005. Epub 2021 Jul 16.